Model Systems for Fragile X Pre-Mutation and Primary Ovarian Insufficiency (FX-POI) (R21)
The summary for the Model Systems for Fragile X Pre-Mutation and Primary Ovarian Insufficiency (FX-POI) (R21) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Model Systems for Fragile X Pre-Mutation and Primary Ovarian Insufficiency (FX-POI) (R21): The purpose of this funding opportunity announcement (FOA) is to stimulate the development of new model systems and/or the thorough characterization of the ovarian phenotype of existing models of fragile X associated premature ovarian insufficiency (FX-POI). New and well-characterized models of FX-POI will help us to answer fundamental questions about the role of the FMR1 repeat expansion in ovarian function and reproductive aging, and allow the field to advance into evidence based clinical research on fragile X pre-mutation carriers who are at risk for POI.
Federal Grant Title: | Model Systems for Fragile X Pre-Mutation and Primary Ovarian Insufficiency (FX-POI) (R21) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health Income Security and Social Services |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PAR-11-137 |
Type of Funding: | Grant |
CFDA Numbers: | 93.865 |
CFDA Descriptions: | Child Health and Human Development Extramural Research |
Current Application Deadline: | Jun 01, 2012 |
Original Application Deadline: | Jun 01, 2012 |
Posted Date: | Mar 09, 2011 |
Creation Date: | Mar 09, 2011 |
Archive Date: | Jul 02, 2012 |
Total Program Funding: | |
Maximum Federal Grant Award: | $200,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Foreign (non-U.S.) components of U.S. Organizations are allowed.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]] - Similar Government Grants
- • Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allo...
- • National Centers for Translational Research in Reproduction and Infertility (NCTRI) (P50 C...
- • Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescen...
- • Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed)
- • Biological Testing Facility (X01 Clinical Trial Not Allowed)
- • Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Precli...
- • Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Precli...
- • Reproductive Genetics and Epigenetics
- More Grants from the National Institutes of Health
- • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...
- • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...
- • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...
- • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
- • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...